Latest in Cardiology from ACC.org

• Eagle’s Eye View: Oral Semaglutide for Weight Loss; Anticoagulants for PAH; The ECDP on TR Evaluation and Management
  In this week’s View, Dr. Eagle looks at the value of oral semaglutide for weight loss. He then explores whether anticoagulants improve survival in patients with pulmonary arterial hypertension (PAH).
• Nicole Bhave, MD, FACC, Named ACC Annual Scientific Session Vice Chair
  The ACC has named Nicole Martin Bhave, MD, FACC, as the next Annual Scientific Session vice chair for ACC.27 and ACC.28. Her term will be followed by a two-year term as chair for ACC.29 and ACC.30.
• Nearly Everyone Has One or More CV Risk Factors Before a CVD Event
  Almost all individuals (99%) who experienced a cardiovascular disease event were exposed to one or more nonoptimal traditional risk factor, challenging the belief that cardiovascular disease often strikes people without warning, according to a large study published Sept. 29 in JACC.
• Editors' Corner | Making AI An Ally in CV Care
  Artificial Intelligence (AI) has become commonplace, affecting most facets of daily life, and the field of medicine is no exception. Now the question is how do we harness these new and emerging tools and make them an ally in cardiovascular care?
• Cover Story | Empowering the AI-Enabled Clinician
  As health care increasingly moves toward tech-enabled care delivery, both clinicians and patients must shift their mindset to recognizing digital tools not just as add-ons, but as essential drivers of high quality, patient-centered care.